New treatment strategies in amyotrophic lateral sclerosis: solutions or illusions?

A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.

European journal of neurology·2014

Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1(G⁹³A) mice.

Neuroscience·2012

Response of mouse brain perfusion to hypo- and hyperventilation measured by arterial spin labeling.

Magnetic resonance in medicine·2011

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.

Neurology·2011

Mutations in SACS cause atypical and late-onset forms of ARSACS.

Neurology·2010

Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.

Neurology·2010

Comparisons between anosmia and ageusia with neurological symptoms and cardiorespiratory fitness among post-COVID-19 individuals: a cross-sectional study.

Acta neurologica Belgica·2026

Prevalence and clinical characterization of headache in patients with cranial bone defects: a single-center retrospective study.

Acta neurologica Belgica·2026

The relationship between health fatalism and caregiver burden in caregivers of patients with multiple sclerosis.

Acta neurologica Belgica·2026

Safety and efficacy of anti-CD20 monoclonal antibodies versus teriflunomide in relapsing multiple sclerosis: a systematic review and meta-analysis.

Acta neurologica Belgica·2026

Exercise-induced neuropeptidergic and neurochemical neuroadaptation in stress regulation and emotional disorders.

Acta neurologica Belgica·2026

Cardiac cephalalgia: an underrecognized cause of secondary headache - a retrospective study.

Acta neurologica Belgica·2026

Concealed cardiomyopathy in sudden childhood death: translation from molecular autopsy to family assessment.

European journal of human genetics : EJHG·2026

Gain-of-function suppressors restore microtubule dynamics and rescue dominant-negative tubulinopathies.

Nature cell biology·2026

[4-Repeat Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration].

Fortschritte der Neurologie-Psychiatrie·2026

Neurofibromatosis 1 (NF1) gene testing reveals rising variant allele fraction as an early warning sign of juvenile myelomonocytic leukemia.

European journal of medical genetics·2026

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.

Experimental neurology·2026

Selective Neuroprotection in the ALS-FTD Spectrum: Mechanisms of Neuronal Resilience and Translational Perspectives.

Brain research bulletin·2026

Related Experiment Videos

New treatment strategies in amyotrophic lateral sclerosis: solutions or illusions?

Related Concept Videos

A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.

Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1(G⁹³A) mice.

Response of mouse brain perfusion to hypo- and hyperventilation measured by arterial spin labeling.

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.

Mutations in SACS cause atypical and late-onset forms of ARSACS.

Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.

Comparisons between anosmia and ageusia with neurological symptoms and cardiorespiratory fitness among post-COVID-19 individuals: a cross-sectional study.

Prevalence and clinical characterization of headache in patients with cranial bone defects: a single-center retrospective study.

The relationship between health fatalism and caregiver burden in caregivers of patients with multiple sclerosis.

Safety and efficacy of anti-CD20 monoclonal antibodies versus teriflunomide in relapsing multiple sclerosis: a systematic review and meta-analysis.

Exercise-induced neuropeptidergic and neurochemical neuroadaptation in stress regulation and emotional disorders.

Cardiac cephalalgia: an underrecognized cause of secondary headache - a retrospective study.

Concealed cardiomyopathy in sudden childhood death: translation from molecular autopsy to family assessment.

Gain-of-function suppressors restore microtubule dynamics and rescue dominant-negative tubulinopathies.

[4-Repeat Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration].

Neurofibromatosis 1 (NF1) gene testing reveals rising variant allele fraction as an early warning sign of juvenile myelomonocytic leukemia.

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery.

Selective Neuroprotection in the ALS-FTD Spectrum: Mechanisms of Neuronal Resilience and Translational Perspectives.

Related Experiment Videos

New treatment strategies in amyotrophic lateral sclerosis: solutions or illusions?

Related Concept Videos

Related Articles